← Eichor
Study identifier: NCT06531473 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures

Condition: Urologic Diseases · Prostate Obstruction  ·  Sponsor: Northwestern University

PhaseNA
Planned participants300
Who can joinMale, 18 Years to 89 Years
Healthy volunteersNo

About this study

The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate. There is currently no gold-standard laser settings for HoLEP procedures. In the investigator's current high-volume practice, the following settings for enucleation are: 2j 50hz. These settings are conventional settings, but there is no literature to prove optimal laser settings. The investigators hypothesizes that utilization of higher laser settings may be associated with a clinically significant (defined as \> 10%) decrease in procedural time without any detrimental postoperative outcomes, and a utilization of lower laser settings may be associated with a clinically significant (defined as \>10%) reduction in postoperative irritative voiding symptoms without any detrimental postoperative outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Allaa Fadl-Alla, BS  ·  312-724-3840  ·  allaa.fadlalla@northwestern.edu

Alyssa McDonald, MS  ·  312-724-3840  ·  alyssa.mcdonald@northwestern.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Northwestern MedicineChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06531473